Effects of adrenomedullin and PAMP on membrane potential and neurotransmission

Peptides

Volumn 21, Issue 2, 2000, Pages 257-263

  Goto, Kenichi ^a   Fujii, Koji ^a   Onaka, Uran ^a   Abe, Isao ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adrenomedullin; ATP sensitive K+ channels; Mesenteric artery; Proadrenomedullin N terminal 20 peptide; Rat; Sympathetic neurotransmission

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENOMEDULLIN; GLIBENCLAMIDE; N(G) NITROARGININE; OMEGA CONOTOXIN GVIA; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROADRENOMEDULLIN; PROADRENOMEDULLIN[1-20]; PROADRENOMEDULLIN[9-20]; PURINE RECEPTOR; SURAMIN; TETRODOTOXIN; UNCLASSIFIED DRUG;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DRUG MECHANISM; EXCITATORY JUNCTION POTENTIAL; HYPERPOLARIZATION; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; MICROELECTRODE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; ELECTRIC STIMULATION; GLYBURIDE; MALE; MEMBRANE POTENTIALS; MESENTERY; MICROELECTRODES; MUSCLE, SMOOTH, VASCULAR; PEPTIDE FRAGMENTS; PEPTIDES; PROTEINS; RATS; RATS, WISTAR; SURAMIN; SYNAPTIC TRANSMISSION; VASODILATOR AGENTS;

EID: 0034032024     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00204-1     Document Type: Article

References (38)

1. 2+ channel blockers on noradrenaline release and purinergic neuroeffector transmission in rat tail artery. Br J Pharmacol. 126:1999;11-18.
2. 2-terminal 20 peptide in the hindquarters vascular bed of the rat. Peptides. 18:1996;513-519.
3. 2-terminal 20 peptide has cAMP-mediated vasodilator activity in the mesenteric vascular bed of the cat. Peptides. 17:1996;1379-1387.
4. 2-terminal 20 peptide has direct vasodilator activity in the cat. Am J Physiol. 272:1997;R1047-R1054.
5. 2-purinoceptor antagonist in the mouse vas deferens . Br J Pharmacol. 93:1988;243-245.
6. Ellis J.L., Burnstock G. Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens. Br J Pharmacol. 97:1989;1157-1164.
7. Feng C.J., Kang B., Kaye A.D., Kadowitz P.J., Nossaman B.D. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci. 55:1994;433-438.
8. Fujii K. Evidence for adenosine triphosphate as an excitatory transmitter in guinea-pig, rabbit, and pig urinary bladder. J Physiol. 404:1988;39-52.
9. Fujii K., Tominaga M., Ohmori S., Kobayashi K., Koga T., Takata Y., Fujishima M. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res. 70:1992;660-669.
10. Hayakawa H., Hirata Y., Kakoki M., Suzuki Y., Nishimatsu H., Nagata D., Suzuki E., Kikuchi K., Nagano T., Kangawa K., Matsuo H., Sugimoto T., Omata M. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension. 33:1999;689-693.
11. Hirata Y., Hayakawa H., Suzuki Y., Suzuki E., Ikenouchi H., Kohmoto O., Kitamura K., Eto T., Kangawa K., Matsuo H., Omata M. Mechanism of adrenomedullin-induced vasodilation in the rat kidney. Hypertension. 25:1995;790-795.
12. Hirning L., Fox A., McCleskey E., Olivera B., Thayer S., Miller R., Tsien R. Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. Science. 239:1988;57-61.
13. Ishizuka Y., Ishizaka Y., Tanaka M., Kitamura K., Kangawa K., Minamino N., Matsuo H., Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Comm. 200:1994;642-646.
14. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin a novel hypotensive peptide isolated from human pheochromocytoma . Biochem Biophys Res Comm. 192:1993;553-560.
15. Kitamura K., Kangawa K., Ishiyama Y., Washimine H., Ichiki Y., Kawamoto M., Minamino N., Matsuo H., Eto T. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett. 351:1994;35-37.
16. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Comm. 194:1993;720-725.
17. Kuwasako K., Kitamura K., Ishiyama Y., Washimine H., Kato J., Kangawa K., Eto T. Purification and characterization of PAMP-12 [PAMP(9-20)] in porcine adrenal medulla as a major endogenous biologically active peptide. FEBS Lett. 414:1997;105-110.
18. Lang M.G., Paterno R., Faraci F.M., Heistad D.D. Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles. Stroke. 28:1997;181-185.
19. Mahata M., Mahata S.K., Parmer R.J., O' Connor D.T. Proadrenomedullin N-terminal 20 peptide minimal active region to regulate nicotinic receptors . Hypertension. 32:1998;907-916.
20. Msghina M., Gonon F., Stjärne L. Facilitation and depression of ATP and noradrenaline release from sympathetic nerves of rat tail artery. J Physiol. 515:1999;523-531.
21. Nossaman BD, Feng CJ, Kaye AD, DeWitt BJ, Coy DH, Murphy WA, Kadowitz PJ. Pulmonary vasodilator responses to adrenomedullin are reduced by nitric oxide synthetase inhibitors in the rat but not in the cat. Am J Physiol 1996; 270:L782-9.
22. Onaka U., Fujii K., Abe I., Fujishima M. Enhancement by exogenous and locally generated angiotensin II of purinergic neurotransmission via angiotensin type 1 receptor in the guinea-pig isolated mesenteric artery. Br J Pharmacol. 122:1997;942-948.
23. Pruneau D., Angus P.D. ω-Conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries. Br J Pharmacol. 100:1990;180-184.
24. ATP channels. J Surg Res. 67:1997;163-168.
25. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Matsuo H., Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Comm. 195:1993;921-927.
26. + channel in insulin-secreting cells. J Biol Chem. 262:1987;15840-15844.
27. Shimosawa T., Fujita T. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension. 28:1996;325-329.
28. 2 -terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest. 96:1995;1672-1676.
29. Sneddon P., Burnstock G. ATP as a co-transmitter in rat tail artery. Eur J Pharmacol. 106:1984;149-152.
30. Sneddon P., Westfall D.P. Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol. 347:1984;561-580.
31. Stjärne L. New paradigm sympathetic transmission by multiple messengers and lateral interaction between monoquantal release sites? Trends Neurosci. 9:1986;547-548.
32. Tadano K., Yamasaki T., Matsumura Y. Inhibitory effects of proadrenomedullin N-terminal 20 peptide on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs. J Pharmacol Exp Ther. 288:1999;522-528.
33. 2+ channel current through a pertussis toxin-sensitive G protein in rat pheochromocytoma derived PC12 cells. J Clin Invest. 98:1996;14-17.
34. Tare M., Parkington H.C., Coleman H.A., Neild T.O., Dusting G.J. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 346:1990;69-71.
35. Trachte G.J. Angiotensin effects on vas deferens adrenergic and purinergic neurotransmission. Eur J Pharmacol. 146:1988;261-269.
36. von Kügelgen I., Starke K. Noradrenaline-ATP cotransmission in the sympathetic nervous system. Trends Pharmacol Sci. 12:1991;319-324.
37. Washimine H., Kitamura K., Ichiki Y., Yamamoto Y., Kangawa K., Matsuo H., Eto T. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma, and urine. Biochem Biophys Res Comm. 202:1994;1081-1087.
38. + channel activated by calcitonin gene related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 507-1998;1:117-29.